Jay Shah

Congrats to you and entire set of team for a good set of numbers, given the tough environment that businesses are operating in. I just had a question on bisglycinate. Basically, we had two major customers in the US.

Okay. And the second thing is, you'd said when we met at one of the conferences, you'd said that Q2 would show a large amount of cost pass -through for phosphates. So, has it been happening or has it already factored in in this 30% odd growth from 85% to 105% odd that we've done year-on-year in PFN? So, is it a lot of phosphate price pass-through in that making?

Okay. And sir, just one last question for you and the management team. If you can just broaden out three, four years out with Nandesari coming in and the SAM also, hopefully, we'll be shipping good volumes. If you have to name two, three sectors or rather, I would say, not sectors, but even if two, three product lines specifically, which is what gives you confidence that the long-term growth target that we have of…

Hi can you hear me?

Good morning Ashish and team. And congratulations on a great set of numbers. So, Ashish, my question is a little bit strategic, if you see, you know, the last few years we have been on a heavy capex journey, and because casting, forging, you know, it's an industry that takes time for things to come on stream.

Okay, okay, understood. And, and on the industrial side, you don't think there is, going to be a heavy base or something that's going to affect you because the tailwinds are much stronger even than passenger vehicle sector, right?